Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
US6986891B2 · kind B2 · utility
1Cited by
0References
25Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 28, 2001 |
| Grant date | Jan 17, 2006 |
| Priority date | — |
| Expiry date | Nov 28, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to cell surface antigens found on myeloma cells and on ovarian cancer cells, and monoclonal antibodies, and antibody binding fragments thereof, capable of being used for therapeutic, diagnostic, detection and cell purification purposes. An exemplified monoclonal antibody of the present invention recognizes and binds to an epitope common to surface antigen expressed on multiple myeloma cells and on ovarian cancer cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.